Earnings Feed
Start Free
Home/Filings/4/0001415889-24-024040
4//SEC Filing

Morgen Eric 4

Accession 0001415889-24-024040

CIK 0001709941other
View on SEC.govCompany Profile

Filed

Sep 26, 8:00 PM ET

Accepted

Sep 27, 4:17 PM ET

Size

11.1 KB

Accession

0001415889-24-024040

Insider Transaction Report

Form 4
Period: 2024-04-17
BioAge Labs, Inc.BIOA
Morgen Eric
DirectorChief Operating Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-04-17+13,598→ 13,598 total(indirect: By Spouse)
    Exercise: $8.39Exp: 2034-04-16→ Common Stock (13,598 underlying)
  • Award

    Stock Option (Right to Buy)

    2024-09-25+4,952→ 4,952 total(indirect: By Spouse)
    Exercise: $18.00Exp: 2034-09-24→ Common Stock (4,952 underlying)
  • Award

    Stock Option (Right to Buy)

    2024-04-17+257,973→ 257,973 total
    Exercise: $8.39Exp: 2034-04-16→ Common Stock (257,973 underlying)
Footnotes (5)
  • [F1]The option shall vest as to 1/48th of the total award monthly, with the first tranche vesting on October 1, 2024, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.
  • [F2]Represents an employee stock option directly held by the reporting person's spouse.
  • [F3]This option award represents an equity security previously reported on the reporting person's Form 3, which was acquired through an exempt transaction with the Issuer prior to the Issuer registering a class of equity securities under Section 12 of the Securities Exchange Act of 1934, as amended. It is reported herein as a transaction pursuant to Rule 16a-2(a).
  • [F4]The option vested or vests as to 1/48th of the total award monthly, with the first tranche vesting on May 17, 2024, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date. Additionally, the entire award is exercisable at any time pursuant to an early exercise feature of the option award.
  • [F5]The option vested or vests as to 1/48th of the total award monthly, with the first tranche vesting on May 17, 2024, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.

Documents

1 file

Issuer

BioAge Labs, Inc.

CIK 0001709941

→
Entity typeother

Related Parties

1
  • filerCIK 0002036289

Filing Metadata

Form type
4
Filed
Sep 26, 8:00 PM ET
Accepted
Sep 27, 4:17 PM ET
Size
11.1 KB
View on SEC.gov